Thursday 17 January 2019


                                      Plan your trip to Osaka, Japan



Theme: Promulgating the prevention of adverse drug reaction

The conference offers richer experiences for Exhibitors, Sponsors, Plenary Sessions, keynote talks, Poster presentations, B2B meetings, and networking panels.
For Conference details, please visit
https://bit.ly/2HwRNwR

Benefits
·         Best platform to develop new partnership & collaborations.
·         Network development with both Academia and Business.
·         Recognition to your products and services in the world market through our website.
·         Shape and raise your corporate image through logo branding.
·         Special privileges on group registrations.
·         Develop new client relationships and strengthen the existing ones (B2B Meeting).

Participating Companies:
·         Abbvie,USA
·         E&Y, China
·         Salmanz Group, Australia
·         Nucleon Therapetics, India
·         Saudi Patient safety Center, Saudi
·         AlphaBeta Pharma, UK
·         King Abdullah Medical City (KAMC)
·         Takeda, USA
Please let me know your confirmation at the earliest convenience.

  Best Regards
  Zoey A Williams| Program Coordinator
  Global Pharmacovigilance 2019
  Ph: 4896666555 Ext:6028
  Email:  globalpharmocovigilance2019@gmail.com

1 comment: